GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its stake in shares of Innoviva, Inc.

But while topline results, published in May, suggest its new drug Relvar Ellipta is a step forward in treatment, the full trial data paints a more down-to-earth reality – with some disappointing ...

Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. , today announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, ...